Cargando…
Human growth hormone use in poor ovarian response – caution and opportunities
Human growth hormone has found favour as a co-gonadotrophin in assisted reproduction particularly in the circumstances of a poor response to stimulation. Its use has been based on animal studies suggesting insulin-like growth factor-1 enhances granulosa and cumulus cell function and possibly oocyte...
Autores principales: | Norman, Robert J., Hart, Roger J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7983244/ https://www.ncbi.nlm.nih.gov/pubmed/33796856 http://dx.doi.org/10.1177/2633494121999420 |
Ejemplares similares
-
Poor ovarian response and the possible role of natural and modified natural cycles
por: Di Guardo, Federica, et al.
Publicado: (2022) -
Type and dose of gonadotropins in poor ovarian responders:
does it matter?
por: Boudry, Liese, et al.
Publicado: (2021) -
Double or dual stimulation in poor ovarian responders: where do we stand?
por: Polat, Mehtap, et al.
Publicado: (2021) -
The rate of high ovarian response in women identified at risk by a high serum AMH level is influenced by the type of gonadotropin
por: Arce, Joan-Carles, et al.
Publicado: (2014) -
High Pretreatment Plasma D-dimer Levels Are Associated With Poor Prognosis in Patients With Ovarian Cancer Independently of Venous Thromboembolism and Tumor Extension
por: Sakurai, Manabu, et al.
Publicado: (2015)